Akebia Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 34 U.S.-traded ETFs. AKBA has around 8.5M shares in the U.S. ETF market. The largest ETF holder of AKBA is the iShares Russell 2000 ETF (IWM), with approximately 2.63M shares. Investors may also find of interest that the ETF with the largest allocation to AKBA stock is Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a portfolio weight of 1.24%. On average, U.S. ETFs allocate 0.09% of AKBA to their portfolios.
Additionally, AKBA is a favorite stock for Vanilla and Exchange-specific ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with AKBA as a holding is the Principal Healthcare Innovators Index ETF (BTEC), with a return of 17.23%.